Flatiron Health, United States
Flatiron Health (Employment, Ownership Interest includes stock, stock options, patent or other intellectual property)
Comparison of Denosumab versus Bisphosphonates on Progression-free and Overall Survival in Newly Diagnosed Multiple Myeloma: A New User, Active Comparator Analysis of Real-World Data
Sunday, August 28, 20222:15 PM - 2:30 PM CEST
